Metastatic colorectal cancer is more advanced in younger patients than in older ones, but they survive longer
Metastatic colorectal cancer (mCRC) continues to increase among patients 45 and younger. Their longer survival and different disease patterns compared with older patients may warrant closer scrutiny of gastrointestinal symptoms, according to new study findings.
A recent study presented at the American College of Surgeons' Clinical Congress 2026 reveals that metastatic colorectal cancer (mCRC) is more advanced in younger patients than in older patients. Despite this advanced disease, younger patients tend to survive longer. The research, which analyzed data from the Surveillance, Epidemiology and End Results (SEER) Program database between 2004 and 2024, involved 50,802 patients with metastatic colorectal cancer.
Out of these, 4,256 (8.4%) were 45 years or younger. Younger patients exhibited a median disease-specific survival of 32 months, compared to 22 months for older patients. They also experienced a higher rate of 10-year survival (17.8% vs. 11.4%). Although the study found younger patients to have a higher incidence of left-sided colon or rectal tumors, evidence suggesting their disease was more advanced was not conclusive.
The findings highlight the need for greater awareness among primary care doctors and gastroenterologists regarding nonspecific gastrointestinal symptoms in younger patients, as early detection could potentially improve their outcomes.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
